137 related articles for article (PubMed ID: 27286171)
1. CYP2J2 - regulation, function and polymorphism.
Murray M
Drug Metab Rev; 2016 Aug; 48(3):351-68. PubMed ID: 27286171
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.
Xu M; Ju W; Hao H; Wang G; Li P
Drug Metab Rev; 2013 Aug; 45(3):311-52. PubMed ID: 23865864
[TBL] [Abstract][Full Text] [Related]
3. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
Spiecker M; Darius H; Hankeln T; Soufi M; Sattler AM; Schaefer JR; Node K; Börgel J; Mügge A; Lindpaintner K; Huesing A; Maisch B; Zeldin DC; Liao JK
Circulation; 2004 Oct; 110(15):2132-6. PubMed ID: 15466638
[TBL] [Abstract][Full Text] [Related]
4. CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design.
Das A; Weigle AT; Arnold WR; Kim JS; Carnevale LN; Huff HC
Pharmacol Ther; 2020 Nov; 215():107601. PubMed ID: 32534953
[TBL] [Abstract][Full Text] [Related]
5. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366
[TBL] [Abstract][Full Text] [Related]
6. Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes.
Nakayama K; Nitto T; Inoue T; Node K
Life Sci; 2008 Aug; 83(9-10):339-45. PubMed ID: 18675280
[TBL] [Abstract][Full Text] [Related]
7. CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.
Li R; Xu X; Chen C; Wang Y; Gruzdev A; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E270-82. PubMed ID: 25389363
[TBL] [Abstract][Full Text] [Related]
8. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome p450 epoxygenase promotes human cancer metastasis.
Jiang JG; Ning YG; Chen C; Ma D; Liu ZJ; Yang S; Zhou J; Xiao X; Zhang XA; Edin ML; Card JW; Wang J; Zeldin DC; Wang DW
Cancer Res; 2007 Jul; 67(14):6665-74. PubMed ID: 17638876
[TBL] [Abstract][Full Text] [Related]
10. Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
Chen F; Chen C; Yang S; Gong W; Wang Y; Cianflone K; Tang J; Wang DW
PLoS One; 2012; 7(6):e39197. PubMed ID: 22761738
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in the G-50T polymorphism of the cytochrome P450 epoxygenase CYP2J2 gene and the risk of younger onset type 2 diabetes among Chinese population: potential interaction with body mass index and family history.
Wang CP; Hung WC; Yu TH; Chiu CA; Lu LF; Chung FM; Hung CH; Shin SJ; Chen HJ; Lee YJ
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):346-52. PubMed ID: 20140850
[TBL] [Abstract][Full Text] [Related]
12. The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile.
Börgel J; Bulut D; Hanefeld C; Neubauer H; Mügge A; Epplen JT; Holland-Letz T; Spiecker M
BMC Cardiovasc Disord; 2008 Dec; 8():41. PubMed ID: 19105833
[TBL] [Abstract][Full Text] [Related]
13. Endothelium-specific CYP2J2 overexpression attenuates age-related insulin resistance.
Yang Y; Dong R; Chen Z; Hu D; Fu M; Tang Y; Wang DW; Xu X; Tu L
Aging Cell; 2018 Apr; 17(2):. PubMed ID: 29318723
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450-derived eicosanoids and heart function.
Jamieson KL; Endo T; Darwesh AM; Samokhvalov V; Seubert JM
Pharmacol Ther; 2017 Nov; 179():47-83. PubMed ID: 28551025
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.
Liu PY; Li YH; Chao TH; Wu HL; Lin LJ; Tsai LM; Chen JH
Atherosclerosis; 2007 Nov; 195(1):199-206. PubMed ID: 17126841
[TBL] [Abstract][Full Text] [Related]
16. Role of activator protein-1 in the down-regulation of the human CYP2J2 gene in hypoxia.
Marden NY; Fiala-Beer E; Xiang SH; Murray M
Biochem J; 2003 Aug; 373(Pt 3):669-80. PubMed ID: 12737630
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory ω-3 endocannabinoid epoxides.
McDougle DR; Watson JE; Abdeen AA; Adili R; Caputo MP; Krapf JE; Johnson RW; Kilian KA; Holinstat M; Das A
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6034-E6043. PubMed ID: 28687674
[TBL] [Abstract][Full Text] [Related]
18. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.
Shahabi P; Siest G; Meyer UA; Visvikis-Siest S
Pharmacol Ther; 2014 Nov; 144(2):134-61. PubMed ID: 24882266
[TBL] [Abstract][Full Text] [Related]
19. The common functional polymorphism -50G>T of the CYP2J2 gene is not associated with ischemic coronary and cerebrovascular events in an urban-based sample of Swedes.
Fava C; Montagnana M; Almgren P; Hedblad B; Engström G; Berglund G; Minuz P; Melander O
J Hypertens; 2010 Feb; 28(2):294-9. PubMed ID: 19851119
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric Binding and Metabolism of Polyunsaturated Fatty Acids (PUFAs) by CYP2J2 Epoxygenase.
Arnold WR; Baylon JL; Tajkhorshid E; Das A
Biochemistry; 2016 Dec; 55(50):6969-6980. PubMed ID: 27992998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
